NCT00349180已完成3 期
Multicenter, Randomized, Double-Blind Study to Evaluate the Efficacy and Safety of Enoxaparin Sodium（RP54563）20mg qd and 20mg Bid for 14 Days in Patients With Total Hip Replacement
适应症
相关药物
试验速览
- 阶段
- 3 期
- 状态
- 已完成
- 发起方
- Sanofi
- 入组人数
- 156
- 试验地点
- 1
- 主要终点
- Incidence of VTE
研究概览
简要总结
This study is performed to confirm the optimal dose for THR (total hip replacement).
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Prevention
- 盲法
- Double
入排标准
- 年龄范围
- 20 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Patients undergoing elective primary THR (total hip replacement) surgery
排除标准
- •Patient with risk of clinical significant bleeding
结局指标
主要结局
Incidence of VTE
次要结局
- Incidence of bleeding
研究者
研究点 (1)
Loading locations...
相似试验
已完成
不适用
Study Comparing BoneMaster Hydroxyapatite Coating With Plasma-sprayed Hydroxyapatite Coating on Acetabular CupsArthropathy of HipNCT00859976Zimmer Biomet167
终止
3 期
A Study to Evaluate the Effectiveness and Safety of Tapentadol(CG5503) in the Treatment of Acute Pain After Hip Replacement Surgery Compared With Oxycodone and Placebo Followed by a Voluntary Open-Label Extension For SafetyArthroplastyNCT00364533Johnson & Johnson Pharmaceutical Research & Development, L.L.C.367
Unknown
不适用
Furlong Evolution® Hip TrialFocus: A Multicentre Prospective Clinical Surveillance Study Aims to Assess the Clinical, Functional and Radiological Outcome of the Furlong Evolution® Hip StemNCT01721278Imperial College London700
终止
2 期
A Study to Evaluate THR-687 Treatment for Diabetic Macular Oedema.Diabetic Macular EdemaDiabetes MellitusDiabetic RetinopathyNCT05063734Oxurion16
已完成
3 期
Efficacy and Safety of Adalimumab in Pediatric Subjects With Moderate to Severe Ulcerative ColitisUlcerative ColitisNCT02065557AbbVie101